Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY)

Aclaris Therapeutics, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are both Biotechnology companies. Aclaris Therapeutics, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are of similar size ($524.8M and $513.7M). Aclaris Therapeutics, Inc. has the higher net margin (−921.5% vs −89,724.2%) and the lower return on invested capital (−163.4% vs 0.00%). Across the 15 metrics below, Aclaris Therapeutics, Inc. leads on 8 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 7.

Valuation

Metric ACRS CYVNY Biotechnology median
P/E n/m n/m 8.50
P/S 56.96 2.37 9.71
P/B 3.76 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 47.13 759.28 9.21
Earnings yield (17.68%) (2,375.00%) (33.15%)
Free cash flow yield (13.28%) (84,379.36%) (25.50%)

Profitability

Metric ACRS CYVNY Biotechnology median
Gross margin 12.90% 0.00% 65.16%
Operating margin (1,050.16%) 0.00% 0.00%
Net margin (921.50%) (89,724.18%) 0.00%
Free cash flow margin (756.50%) 0.00% 0.00%
Return on equity (59.10%) 0.00% (56.36%)
Return on assets (41.07%) 0.00% (48.04%)
Return on invested capital (163.35%) 0.00% 0.00%

Growth

Metric ACRS CYVNY Biotechnology median
Revenue growth (TTM) (51.04%) — 6.02%
EPS growth (last fiscal year) 69.01% 61.59% 30.26%
Revenue growth, 5-year CAGR 3.84% (15.81%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRS CYVNY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.46 0.22 4.72
Net debt to EBITDA 1.20 0.31 0.96

Dividend

Metric ACRS CYVNY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACRS CYVNY Biotechnology median
Market cap 513.72m 524.83m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack